The Medicines for Human Use and Medical Devices (Fees Amendments) Regulations 2007

This document cites

• European Communities Act 1972
• Finance Act 1973
• Medicines Act 1971
• Health and Medicines Act 1988
• Medicines Act 1968



See all quotations

• Northern Ireland Act 2000
• Northern Ireland Act 1998
• European Communities (Designation) (No. 3) Order 1991
• Medicines for Human Use and Medical Devices(Fees Amendments) Regulations 2003
• Departments (Northern Ireland) Order 1999
• The Veterinary Medicines Regulations 2006
• Medical Devices (Consultation Requirements) (Fees) Regulations 1995
• Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994
• Medicines (Homoeopathic Medicinal Products for Human Use) Amendment Regulations 2005
• Medicines (Products for Human Use-Fees) Amendment Regulations 1996
• The Medicines for Human Use (Manufacturing, Wholesale Dealing and Miscellaneous Amendments) Regulations 2005
• Medical Devices Regulations 2002
• Medicines for Human Use and Medical Devices (Fees and Miscellaneous Amendments) Regulations 2002
• The Medicines for Human Use (Fees Amendments)(No. 2) Regulations 2005
• The Medicines for Human Use and Medical Devices (Fees Amendments) Regulations 2006
• Transfer of Functions (Medicines and Poisons) Order 1999
• Transfer of Functions (Wales) Order 1969
• Medicines (Homoeopathic Medicinal Products for Human Use) Amendment Regulations 1996
• Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994
• Medicines (Products for Human Use - Fees) Regulations 1995
• Competition Act 1998 (Consequential and Supplemental Provisions) Order 2000
• Ministry of Agriculture, Fisheries and Food (Dissolution) Order 2002
• The Medicines for Human Use (Clinical Trials Fees Amendments) Regulations 2004
• European Communities (Designation) (No. 3) Order 1993
• The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006
• The Medicines for Human Use (Fees and Miscellaneous Amendments) Regulations 2003
• Commission Regulation (EC) No 1084/2003 of 3 June 2003 concerning the examination of variations to the terms of a marketing authorisation for medicinal products for human use and veterinary medicinal products granted by a competent authority of a Member State (Text with EEA relevance)